Mannose

Generic Name
Mannose
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C6H12O6
CAS Number
3458-28-4
Unique Ingredient Identifier
PHA4727WTP
Background

Mannose is under investigation for the basic science of IUGR and Pregnancy.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Preventing Recurrent Urinary Tract Infections With α-D-mannose

Phase 4
Terminated
Conditions
Urinary Tract Infections
Interventions
Drug: Mannose
Drug: Lactose
First Posted Date
2018-04-13
Last Posted Date
2020-09-02
Lead Sponsor
Kantonsspital Aarau
Target Recruit Count
15
Registration Number
NCT03497598
Locations
🇨🇭

Kantonsspital Aarau, Aarau, Switzerland

Nutraceutical Efficacy for rUTI

Phase 2
Terminated
Conditions
Urinary Tract Infections
Interventions
Drug: D-Mannose
First Posted Date
2018-01-10
Last Posted Date
2022-02-04
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
61
Registration Number
NCT03395288
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Transplacental Gradients and Transport in Intrauterine Growth Restricted (IUGR) Pregnancies Compared to Normal Pregnancies.

Not Applicable
Terminated
Conditions
IUGR
Pregnancy
Interventions
Drug: Placebo
Drug: Mannose
Drug: Myoinositol
First Posted Date
2015-03-24
Last Posted Date
2021-11-11
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
24
Registration Number
NCT02397291
Locations
🇺🇸

University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy